The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

被引：0
|
作者：
Mohammadreza Amirsadri
Sarah Mousavi
Ali Karimipour
机构：
[1] Isfahan University of Medical Sciences,Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences
[2] Isfahan University of Medical Sciences,Isfahan Pharmaceutical Sciences Research Center
[3] Isfahan University of Medical Sciences,School of Pharmacy and Pharmaceutical Sciences
来源：
DARU Journal of Pharmaceutical Sciences | 2019年 / 27卷
关键词：
Economic evaluation; Enoxaparin; Heparin; Venous thromboembolism; Medical inpatients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 634
页数：7
相关论文
共 50 条
  • [1] The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran
    Amirsadri, Mohammadreza
    Mousavi, Sarah
    Karimipour, Ali
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (02) : 627 - 634
  • [2] PROPHYLAXIS OF VENOUS THROMBOEMBOLISM - ANALYSIS OF COST-EFFECTIVENESS
    SALZMAN, EW
    DAVIES, GC
    [J]. ANNALS OF SURGERY, 1980, 191 (02) : 207 - 218
  • [3] Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States
    Guy, Holly
    Laskier, Vicki
    Fisher, Mark
    Neuman, W. Richey
    Bucior, Iwona
    Deitelzweig, Steven
    Cohen, Alexander T.
    [J]. PHARMACOECONOMICS, 2019, 37 (05) : 701 - 714
  • [4] Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States
    Holly Guy
    Vicki Laskier
    Mark Fisher
    W. Richey Neuman
    Iwona Bucior
    Steven Deitelzweig
    Alexander T. Cohen
    [J]. PharmacoEconomics, 2019, 37 : 701 - 714
  • [5] COST-EFFECTIVENESS OF PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
    POWLEY, JM
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1981, 74 (07) : 555 - 555
  • [6] COST-EFFECTIVENESS OF PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
    DAVIES, GC
    SALZMAN, EW
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1981, 74 (03) : 177 - 180
  • [7] Postpartum venous thromboembolism prophylaxis: A Cost-Effectiveness Analysis
    Becker, David A.
    Einerson, Brett D.
    Wetta, Luisa L.
    Kuper, Spencer G.
    Casey, Brian M.
    Subramaniam, Akila
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S487 - S488
  • [8] Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden
    Jonas Lundkvist
    David Bergqvist
    Bengt Jönsson
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4): : 254 - 262
  • [9] A COST-UTILITY ANALYSIS OF PROPHYLACTIC THERAPY FOR VENOUS THROMBOEMBOLISM WITH DABIGATRAN ETEXILATE OR ENOXAPARIN
    Burbano-Levy, X.
    Herran, S.
    Sanchez, G.
    Mieth, K.
    Alfonso-Cristancho, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A535 - A535
  • [10] COST-EFFECTIVENESS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS IN SURGERY
    BERGQVIST, D
    [J]. EUROPEAN JOURNAL OF SURGERY, 1994, : 49 - 53
12345